Coverage
-
March 31, 2011
A Nevada federal judge refused Wednesday to dismiss a Sherman Act counterclaim against Bayer AG in the patent infringement suit it is pursuing against Watson Laboratories Inc. and Sandoz Inc. over their efforts to market a generic version of Yaz.
1 other articles on this case.
View all »